The association between active tumor volume, total lesion glycolysis and levels of S-100B and LDH in stage IV melanoma patients
Author:
Publisher
Elsevier BV
Subject
Oncology,General Medicine,Surgery
Reference46 articles.
1. Systemic treatment for BRAF-mutant melanoma: where do we go next?;Menzies;Lancet Oncol,2014
2. Overall survival with combined nivolumab and ipilimumab in advanced melanoma;Wolchok;N Engl J Med,2017
3. Stage IV melanoma: completely resectable patients are scarce;Wevers;Ann Surg Oncol,2013
4. A new era of proactive melanoma therapy: hit hard, hit early;Haas;Br J Dermatol,2018
5. Conditional survival: an assessment of the prognosis of patients at time points after initial diagnosis and treatment of locoregional melanoma metastasis;Haydu;J Clin Oncol,2017
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients;European Journal of Surgical Oncology;2024-07
2. Reply to: Beyond S100B: The need for new biomarkers in stage III melanoma recurrence detection;European Journal of Surgical Oncology;2024-07
3. Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness;Diagnostics;2024-03-20
4. The role of micrometastasis in high‐risk skin cancers;Australasian Journal of Dermatology;2023-12-29
5. Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab;Oncology;2023-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3